A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Launched by BAYER · Apr 26, 2022
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The FINE-REAL study is looking at how well the medication finerenone works for people with chronic kidney disease (CKD) and type 2 diabetes (T2D) when prescribed by their doctors in everyday medical care. CKD can happen when diabetes damages the kidneys over time, making it harder for them to filter waste from the blood. Finerenone helps protect the kidneys by blocking certain proteins that can cause damage. This study will gather information about patients who have recently started taking finerenone, including why they started, how long they’ve been on it, and if they experienced any side effects, especially high potassium levels, which can be a concern.
To join the study, participants need to be at least 18 years old and have a doctor's diagnosis of CKD linked to T2D. They should have started taking finerenone within the last two months. During the study, which lasts for 12 months, participants will provide information during routine check-ups and may give blood and urine samples to help researchers learn more about the medication's effects over time. This study is important because it aims to better understand how finerenone is used in real-life settings, helping improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult participants of all genders (≥18 years old)
- • Diagnosis of CKD associated with T2D based on assessment by physician.
- • Treatment according to local marketing authorization, finerenone 20 or 10 mg.Treatment should have been started up to 8 weeks before or after the ICF is signed.
- • Decision to initiate treatment with finerenone must be made before ICF is signed.
- • Signed informed consent
- Exclusion Criteria:
- • Participation in an investigational trial at any time during the course of this study
- • Contra-indications according to the local label.
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
West Palm Beach, Florida, United States
Shreveport, Louisiana, United States
Reno, Nevada, United States
Chicago, Illinois, United States
Salt Lake City, Utah, United States
Augusta, Georgia, United States
Greensboro, North Carolina, United States
Charlotte, North Carolina, United States
Harrisburg, Arkansas, United States
Granada Hills, California, United States
Multiple Locations, , Korea, Republic Of
Port Charlotte, Florida, United States
El Paso, Texas, United States
Suwanee, Georgia, United States
Multiple Locations, , Germany
Multiple Locations, , Greece
Multiple Locations, , Taiwan
Los Angeles, California, United States
Alexandria, Virginia, United States
Multiple Locations, , Russian Federation
Multiple Locations, , China
Multiple Locations, , France
Multiple Locations, , Italy
Multiple Locations, , Saudi Arabia
Multiple Locations, , Belgium
Multiple Locations, , Canada
Multiple Locations, , Mexico
Multiple Locations, , Spain
Fall River, Massachusetts, United States
Multiple Locations, , Argentina
Multiple Locations, , Denmark
Multiple Locations, , Netherlands
Multiple Locations, , Thailand
Webster, Texas, United States
Multiple Locations, , Switzerland
Honolulu, Hawaii, United States
Los Angeles, California, United States
Multiple Locations, , Colombia
Chicago, Illinois, United States
Reno, Nevada, United States
Grand Rapids, Michigan, United States
Multiple Locations, , Brazil
Multiple Locations, , Luxembourg
Multiple Locations, , Portugal
Multiple Locations, , Slovenia
Alpharetta, Georgia, United States
Multiple Locations, , Singapore
Huntsville, Alabama, United States
Phoenix, Arizona, United States
Glendale, California, United States
West Covina, California, United States
Orlando, Florida, United States
Alpharetta, Georgia, United States
Brunswick, Georgia, United States
Stockbridge, Georgia, United States
Chicago, Illinois, United States
Hinsdale, Illinois, United States
Slidell, Louisiana, United States
Baltimore, Maryland, United States
Jackson, Mississippi, United States
Tupelo, Mississippi, United States
Edison, New Jersey, United States
Flint, Texas, United States
Houston, Texas, United States
Houston, Texas, United States
Mcallen, Texas, United States
Plano, Texas, United States
Tacoma, Washington, United States
San Francisco, California, United States
Terre Haute, Indiana, United States
Iowa City, Iowa, United States
Memphis, Tennessee, United States
Port Charlotte, Florida, United States
Winston Salem, North Carolina, United States
Multiple Locations, , Chile
Port Charlotte, Florida, United States
Minneapolis, Minnesota, United States
Honolulu, Hawaii, United States
Providence, Rhode Island, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials